Why is $CUE stock up today?
Cue Biopharma, Inc.
Why is $CUE up today?
The likely driver
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
GlobeNewswire Inc.·1:00 PM ETpositive
Price
$31.20
Move today
+12.8%
Volume vs avg
0.0x
Scanner alerts today
0
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.